ClinicalTrials.govpublic full text
S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
leukemia, adult acute monocytic leukemia (m5b), adult acute erythroid leukemia (m6), adult acute megakaryoblastic leukemia (m7), adult acute myeloblastic leukemia with maturation (m2), adult acute myeloblastic leukemia without maturation (m1), adult acute myelomonocytic leukemia (m4), adult acute monoblastic leukemia (m5a), recurrent adult acute myeloid leukemia, secondary acute myeloid leukemia, adult acute myeloid leukemia with t(8;21)(q22;q22), adult acute myeloid leukemia with t(16;16)(p13;q22)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 868160
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.